Loading...

Fixation Buffer Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL NOK487
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  3. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  4. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  5. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  6. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  7. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  8. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  9. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  10. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  11. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  12. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  13. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  14. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  15. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  16. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  17. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  18. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  19. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  20. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  21. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  22. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  23. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  24. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  25. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  26. Chan L, et al. 2022. Cells. 12: . PubMed
  27. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  28. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  29. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  30. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  31. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  32. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  33. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  34. Zander R, et al. 2022. Immunity. 55:475. PubMed
  35. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  36. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  37. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  38. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  39. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  40. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  41. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  42. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  43. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  44. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  45. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  46. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  47. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  48. Wang H, et al. 2023. Nature. 615:339. PubMed
  49. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  50. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  51. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  53. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  54. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  55. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  56. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  57. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  58. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  59. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  60. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  61. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  62. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  63. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  64. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  65. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  66. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  68. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  69. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  70. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  71. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  72. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  73. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  74. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  75. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  79. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  80. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  81. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  82. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  83. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  84. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  85. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  86. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  87. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  88. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  89. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  90. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  91. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  92. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  93. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  94. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  95. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  96. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  97. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  98. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  99. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  100. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  101. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  102. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  103. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  104. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  105. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  106. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  107. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  110. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  111. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  112. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  113. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  114. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  115. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  116. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  117. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  118. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  119. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  120. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  121. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  122. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  123. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  124. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  125. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  126. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  127. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  128. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  129. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  130. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  134. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  135. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  136. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  137. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  138. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  139. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  140. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  141. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  142. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  143. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  144. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  145. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  146. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  147. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  148. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  149. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  150. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  151. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  152. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  153. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  154. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  155. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  156. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  159. Ma K, et al. 2022. iScience. 25:104347. PubMed
  160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  162. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  163. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  164. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  165. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  166. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  167. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  168. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  169. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  170. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  171. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  172. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  173. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  174. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  175. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  176. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  177. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  178. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  179. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  180. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  181. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  182. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  188. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  189. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  190. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  191. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  192. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  193. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  194. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  200. Wang X, et al. 2022. Elife. 11:. PubMed
  201. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  202. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  203. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  204. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  205. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  206. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  207. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  208. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  209. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  210. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  212. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  215. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  216. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  217. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  218. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  219. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  220. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  221. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  222. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  223. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  224. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  225. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  226. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  227. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  228. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  229. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  230. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  231. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  232. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  233. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  234. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  235. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  236. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  237. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  238. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  239. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  240. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  241. Chan L, et al. 2022. Cells. 12: . PubMed
  242. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  243. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  244. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  245. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  246. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  247. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  248. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  249. Zander R, et al. 2022. Immunity. 55:475. PubMed
  250. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  251. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  252. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  253. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  254. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  255. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  256. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  257. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  258. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  259. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  260. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  261. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  262. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  263. Wang H, et al. 2023. Nature. 615:339. PubMed
  264. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  265. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  266. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  267. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  268. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  269. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  270. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  271. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  272. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  273. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  274. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  275. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  276. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  277. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  278. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  279. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  280. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  281. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  282. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  283. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  284. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  285. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  286. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  287. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  288. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  289. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  290. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  291. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  292. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  293. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  294. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  295. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  296. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  297. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  298. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  299. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  300. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  301. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  302. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  303. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  304. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  305. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  306. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  307. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  308. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  309. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  310. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  311. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  312. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  313. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  314. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  315. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  316. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  317. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  318. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  319. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  320. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  321. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  322. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  323. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  324. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  325. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  326. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  327. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  328. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  329. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  330. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  331. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  332. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  333. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  334. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  335. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  336. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  337. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  338. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  339. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  340. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  341. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  342. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  343. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  344. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  345. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  346. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  347. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  348. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  349. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  350. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  351. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  352. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  353. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  354. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  355. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  356. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  357. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  358. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  359. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  360. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  361. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  362. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  363. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  364. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  365. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  366. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  367. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  368. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  369. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  370. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  371. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  372. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  373. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  374. Ma K, et al. 2022. iScience. 25:104347. PubMed
  375. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  376. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  377. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  378. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  379. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  380. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  381. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  382. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  383. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  384. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  385. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  386. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  387. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  388. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  389. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  390. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  391. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  392. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  393. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  394. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  395. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  396. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  397. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  398. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  399. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  400. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  401. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  402. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  403. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  404. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  405. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  406. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  407. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  408. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  409. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  410. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  411. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  412. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  413. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  414. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  415. Wang X, et al. 2022. Elife. 11:. PubMed
  416. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  417. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  418. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  419. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  420. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  421. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  422. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  423. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  424. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  425. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  426. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  427. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  430. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07.25.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL NOK487
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  3. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  4. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  5. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  6. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  7. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  8. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  9. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  10. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  11. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  12. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  13. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  14. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  15. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  16. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  17. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  18. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  19. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  20. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  21. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  22. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  23. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  24. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  25. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  26. Chan L, et al. 2022. Cells. 12: . PubMed
  27. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  28. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  29. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  30. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  31. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  32. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  33. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  34. Zander R, et al. 2022. Immunity. 55:475. PubMed
  35. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  36. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  37. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  38. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  39. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  40. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  41. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  42. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  43. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  44. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  45. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  46. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  47. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  48. Wang H, et al. 2023. Nature. 615:339. PubMed
  49. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  50. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  51. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  53. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  54. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  55. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  56. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  57. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  58. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  59. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  60. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  61. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  62. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  63. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  64. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  65. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  66. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  68. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  69. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  70. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  71. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  72. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  73. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  74. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  75. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  79. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  80. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  81. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  82. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  83. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  84. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  85. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  86. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  87. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  88. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  89. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  90. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  91. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  92. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  93. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  94. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  95. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  96. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  97. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  98. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  99. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  100. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  101. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  102. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  103. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  104. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  105. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  106. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  107. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  110. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  111. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  112. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  113. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  114. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  115. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  116. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  117. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  118. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  119. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  120. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  121. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  122. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  123. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  124. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  125. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  126. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  127. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  128. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  129. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  130. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  134. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  135. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  136. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  137. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  138. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  139. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  140. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  141. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  142. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  143. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  144. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  145. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  146. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  147. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  148. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  149. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  150. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  151. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  152. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  153. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  154. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  155. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  156. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  159. Ma K, et al. 2022. iScience. 25:104347. PubMed
  160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  162. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  163. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  164. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  165. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  166. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  167. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  168. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  169. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  170. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  171. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  172. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  173. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  174. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  175. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  176. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  177. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  178. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  179. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  180. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  181. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  182. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  188. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  189. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  190. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  191. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  192. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  193. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  194. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  200. Wang X, et al. 2022. Elife. 11:. PubMed
  201. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  202. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  203. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  204. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  205. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  206. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  207. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  208. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  209. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  210. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  212. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  215. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  216. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  217. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  218. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  219. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  220. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  221. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  222. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  223. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  224. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  225. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  226. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  227. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  228. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  229. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  230. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  231. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  232. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  233. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  234. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  235. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  236. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  237. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  238. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  239. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  240. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  241. Chan L, et al. 2022. Cells. 12: . PubMed
  242. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  243. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  244. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  245. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  246. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  247. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  248. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  249. Zander R, et al. 2022. Immunity. 55:475. PubMed
  250. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  251. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  252. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  253. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  254. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  255. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  256. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  257. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  258. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  259. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  260. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  261. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  262. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  263. Wang H, et al. 2023. Nature. 615:339. PubMed
  264. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  265. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  266. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  267. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  268. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  269. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  270. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  271. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  272. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  273. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  274. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  275. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  276. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  277. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  278. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  279. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  280. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  281. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  282. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  283. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  284. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  285. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  286. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  287. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  288. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  289. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  290. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  291. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  292. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  293. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  294. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  295. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  296. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  297. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  298. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  299. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  300. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  301. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  302. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  303. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  304. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  305. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  306. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  307. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  308. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  309. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  310. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  311. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  312. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  313. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  314. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  315. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  316. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  317. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  318. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  319. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  320. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  321. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  322. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  323. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  324. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  325. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  326. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  327. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  328. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  329. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  330. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  331. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  332. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  333. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  334. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  335. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  336. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  337. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  338. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  339. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  340. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  341. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  342. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  343. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  344. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  345. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  346. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  347. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  348. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  349. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  350. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  351. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  352. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  353. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  354. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  355. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  356. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  357. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  358. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  359. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  360. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  361. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  362. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  363. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  364. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  365. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  366. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  367. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  368. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  369. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  370. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  371. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  372. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  373. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  374. Ma K, et al. 2022. iScience. 25:104347. PubMed
  375. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  376. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  377. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  378. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  379. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  380. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  381. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  382. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  383. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  384. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  385. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  386. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  387. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  388. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  389. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  390. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  391. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  392. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  393. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  394. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  395. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  396. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  397. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  398. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  399. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  400. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  401. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  402. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  403. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  404. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  405. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  406. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  407. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  408. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  409. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  410. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  411. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  412. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  413. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  414. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  415. Wang X, et al. 2022. Elife. 11:. PubMed
  416. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  417. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  418. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  419. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  420. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  421. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  422. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  423. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  424. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  425. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  426. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  427. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  430. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07.25.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account